Aspirin Safety in Patients with History of Peptic Ulcer Disease

Risk Assessment and Preventive Strategies

The American College of Gastroenterology recommends that H. pylori infection testing should be performed in all aspirin users with a history of gastroduodenal ulcer, as H. pylori infection significantly increases the risk of both uncomplicated and complicated gastroduodenal ulcers in patients taking low-dose aspirin 1
H. pylori eradication is mandatory before starting aspirin treatment in patients with a history of peptic ulcers, according to the American College of Gastroenterology 1
After successful H. pylori eradication, the residual risk of peptic ulcer bleeding due to continued aspirin use is very low, as stated by the American College of Gastroenterology 1

The American Heart Association recommends using the lowest effective dose of aspirin to minimize gastrointestinal risk, with lower doses of aspirin (75 mg/day) carrying a lower risk of gastrointestinal bleeding compared to higher doses 3, 2
The relative risks of upper-GI bleeding for different aspirin doses are: 75 mg (2.3), 150 mg (3.2), and 300 mg (3.9), according to the American College of Chest Physicians 2
Enteric-coated and buffered aspirin preparations do not significantly reduce the risk of major upper-GI bleeding compared to plain tablets, as stated by the American College of Chest Physicians 2, 4

Proton pump inhibitors (PPIs) are highly effective for preventing and treating aspirin-induced peptic ulcers, according to the American College of Chest Physicians 2
In patients with previous ulcer bleeding who took low-dose aspirin, adding a PPI reduced the risk of recurrent bleeding to 0.7% compared to 8.6% with clopidogrel alone, as stated by the American College of Chest Physicians 2

Patients with a history of peptic ulcer disease taking aspirin should avoid concurrent use of non-aspirin NSAIDs, as this combination significantly increases bleeding risk, according to the American College of Chest Physicians 3

Regular monitoring for gastrointestinal symptoms is recommended in patients with a history of peptic ulcer disease who are taking aspirin, as stated by the American College of Chest Physicians 2
Risk factors for increased bleeding that should prompt more intensive monitoring include: age >70 years, previous gastrointestinal bleeding, concurrent use of other medications that increase bleeding risk, thrombocytopenia, coagulopathy, and chronic kidney disease, according to the American Heart Association 5
Long-term PPI treatment in H. pylori-positive patients can accelerate the development of atrophic gastritis, so H. pylori eradication should be performed before starting long-term PPI therapy, as recommended by the American College of Gastroenterology 1, 6